ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cell-free DNA Mutation Diagnostics Market Research Report 2024
Published Date: December 2024
|
Report Code: QYRE-Auto-20I18887
Home | Market Reports | Science| Biological Sciences
Global Cell free DNA Mutation Diagnostics Market Research Report 2024
BUY CHAPTERS

Global Cell-free DNA Mutation Diagnostics Market Research Report 2024

Code: QYRE-Auto-20I18887
Report
December 2024
Pages:82
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Illumina Inc
Natera
Guardant
Freenome Holdings
GRAIL
Exact Sciences Corporation
Foundation Medicine
Biocept
Thermo Fisher Scientific
Roche Diagnostics
Agilent Technologies
Quest Diagnostics Incorporated
Laboratory Corporation of America Holdings
Myriad Genetics
BillionToOne Inc.

Cell-free DNA Mutation Diagnostics Market Size

The global market for Cell-free DNA Mutation Diagnostics was valued at US$ 7070 million in the year 2023 and is projected to reach a revised size of US$ 18810 million by 2030, growing at a CAGR of 15.0% during the forecast period.

Cell-free DNA Mutation Diagnostics Market

Cell-free DNA Mutation Diagnostics Market

Cell-free DNA Mutation Diagnostics is a cutting-edge diagnostic technique that analyzes cell-free DNA (cfDNA) in bodily fluids (typically blood or urine) to detect genetic mutations associated with diseases, especially cancer. cfDNA refers to DNA fragments that are released into the bloodstream when cells die or break down. This method provides a non-invasive alternative to traditional biopsy procedures for detecting genetic mutations, enabling early disease detection, monitoring, and personalized treatment planning.
North American market for Cell-free DNA Mutation Diagnostics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Cell-free DNA Mutation Diagnostics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Cell-free DNA Mutation Diagnostics in Hoispital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Cell-free DNA Mutation Diagnostics include Illumina, Natera, Guardant, Freenome Holdings, GRAIL, Exact Sciences Corporation, Foundation Medicine, Biocept, Thermo Fisher Scientific, Roche Diagnostics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cell-free DNA Mutation Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell-free DNA Mutation Diagnostics.
The Cell-free DNA Mutation Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cell-free DNA Mutation Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cell-free DNA Mutation Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Cell-free DNA Mutation Diagnostics Market Report

Report Metric Details
Report Name Cell-free DNA Mutation Diagnostics Market
Accounted market size in year US$ 7070 million
Forecasted market size in 2030 US$ 18810 million
CAGR 15.0%
Base Year year
Forecasted years 2024 - 2030
Segment by Type
Segment by Application
  • Hoispital
  • Clinic
  • Laboratories
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Illumina, Natera, Guardant, Freenome Holdings, GRAIL, Exact Sciences Corporation, Foundation Medicine, Biocept, Thermo Fisher Scientific, Roche Diagnostics, Agilent Technologies, Quest Diagnostics Incorporated, Laboratory Corporation of America Holdings, Myriad Genetics, BillionToOne
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Cell-free DNA Mutation Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Cell-free DNA Mutation Diagnostics Market growing?

Ans: The Cell-free DNA Mutation Diagnostics Market witnessing a CAGR of 15.0% during the forecast period 2024-2030.

What is the Cell-free DNA Mutation Diagnostics Market size in 2030?

Ans: The Cell-free DNA Mutation Diagnostics Market size in 2030 will be US$ 18810 million.

Who are the main players in the Cell-free DNA Mutation Diagnostics Market report?

Ans: The main players in the Cell-free DNA Mutation Diagnostics Market are Illumina, Natera, Guardant, Freenome Holdings, GRAIL, Exact Sciences Corporation, Foundation Medicine, Biocept, Thermo Fisher Scientific, Roche Diagnostics, Agilent Technologies, Quest Diagnostics Incorporated, Laboratory Corporation of America Holdings, Myriad Genetics, BillionToOne

What are the Application segmentation covered in the Cell-free DNA Mutation Diagnostics Market report?

Ans: The Applications covered in the Cell-free DNA Mutation Diagnostics Market report are Hoispital, Clinic, Laboratories, Others

What are the Type segmentation covered in the Cell-free DNA Mutation Diagnostics Market report?

Ans: The Types covered in the Cell-free DNA Mutation Diagnostics Market report are Kits, Instruments, Services

Recommended Reports

Cancer Diagnostics

Genetic Testing

Molecular Diagnostics

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell-free DNA Mutation Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Kits
1.2.3 Instruments
1.2.4 Services
1.3 Market by Application
1.3.1 Global Cell-free DNA Mutation Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hoispital
1.3.3 Clinic
1.3.4 Laboratories
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell-free DNA Mutation Diagnostics Market Perspective (2019-2030)
2.2 Global Cell-free DNA Mutation Diagnostics Growth Trends by Region
2.2.1 Global Cell-free DNA Mutation Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cell-free DNA Mutation Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 Cell-free DNA Mutation Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 Cell-free DNA Mutation Diagnostics Market Dynamics
2.3.1 Cell-free DNA Mutation Diagnostics Industry Trends
2.3.2 Cell-free DNA Mutation Diagnostics Market Drivers
2.3.3 Cell-free DNA Mutation Diagnostics Market Challenges
2.3.4 Cell-free DNA Mutation Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell-free DNA Mutation Diagnostics Players by Revenue
3.1.1 Global Top Cell-free DNA Mutation Diagnostics Players by Revenue (2019-2024)
3.1.2 Global Cell-free DNA Mutation Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Cell-free DNA Mutation Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cell-free DNA Mutation Diagnostics Revenue
3.4 Global Cell-free DNA Mutation Diagnostics Market Concentration Ratio
3.4.1 Global Cell-free DNA Mutation Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell-free DNA Mutation Diagnostics Revenue in 2023
3.5 Global Key Players of Cell-free DNA Mutation Diagnostics Head office and Area Served
3.6 Global Key Players of Cell-free DNA Mutation Diagnostics, Product and Application
3.7 Global Key Players of Cell-free DNA Mutation Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell-free DNA Mutation Diagnostics Breakdown Data by Type
4.1 Global Cell-free DNA Mutation Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global Cell-free DNA Mutation Diagnostics Forecasted Market Size by Type (2025-2030)
5 Cell-free DNA Mutation Diagnostics Breakdown Data by Application
5.1 Global Cell-free DNA Mutation Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global Cell-free DNA Mutation Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cell-free DNA Mutation Diagnostics Market Size (2019-2030)
6.2 North America Cell-free DNA Mutation Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cell-free DNA Mutation Diagnostics Market Size by Country (2019-2024)
6.4 North America Cell-free DNA Mutation Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell-free DNA Mutation Diagnostics Market Size (2019-2030)
7.2 Europe Cell-free DNA Mutation Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cell-free DNA Mutation Diagnostics Market Size by Country (2019-2024)
7.4 Europe Cell-free DNA Mutation Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell-free DNA Mutation Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific Cell-free DNA Mutation Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cell-free DNA Mutation Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific Cell-free DNA Mutation Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cell-free DNA Mutation Diagnostics Market Size (2019-2030)
9.2 Latin America Cell-free DNA Mutation Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cell-free DNA Mutation Diagnostics Market Size by Country (2019-2024)
9.4 Latin America Cell-free DNA Mutation Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell-free DNA Mutation Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa Cell-free DNA Mutation Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cell-free DNA Mutation Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa Cell-free DNA Mutation Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Details
11.1.2 Illumina Business Overview
11.1.3 Illumina Cell-free DNA Mutation Diagnostics Introduction
11.1.4 Illumina Revenue in Cell-free DNA Mutation Diagnostics Business (2019-2024)
11.1.5 Illumina Recent Development
11.2 Natera
11.2.1 Natera Company Details
11.2.2 Natera Business Overview
11.2.3 Natera Cell-free DNA Mutation Diagnostics Introduction
11.2.4 Natera Revenue in Cell-free DNA Mutation Diagnostics Business (2019-2024)
11.2.5 Natera Recent Development
11.3 Guardant
11.3.1 Guardant Company Details
11.3.2 Guardant Business Overview
11.3.3 Guardant Cell-free DNA Mutation Diagnostics Introduction
11.3.4 Guardant Revenue in Cell-free DNA Mutation Diagnostics Business (2019-2024)
11.3.5 Guardant Recent Development
11.4 Freenome Holdings
11.4.1 Freenome Holdings Company Details
11.4.2 Freenome Holdings Business Overview
11.4.3 Freenome Holdings Cell-free DNA Mutation Diagnostics Introduction
11.4.4 Freenome Holdings Revenue in Cell-free DNA Mutation Diagnostics Business (2019-2024)
11.4.5 Freenome Holdings Recent Development
11.5 GRAIL
11.5.1 GRAIL Company Details
11.5.2 GRAIL Business Overview
11.5.3 GRAIL Cell-free DNA Mutation Diagnostics Introduction
11.5.4 GRAIL Revenue in Cell-free DNA Mutation Diagnostics Business (2019-2024)
11.5.5 GRAIL Recent Development
11.6 Exact Sciences Corporation
11.6.1 Exact Sciences Corporation Company Details
11.6.2 Exact Sciences Corporation Business Overview
11.6.3 Exact Sciences Corporation Cell-free DNA Mutation Diagnostics Introduction
11.6.4 Exact Sciences Corporation Revenue in Cell-free DNA Mutation Diagnostics Business (2019-2024)
11.6.5 Exact Sciences Corporation Recent Development
11.7 Foundation Medicine
11.7.1 Foundation Medicine Company Details
11.7.2 Foundation Medicine Business Overview
11.7.3 Foundation Medicine Cell-free DNA Mutation Diagnostics Introduction
11.7.4 Foundation Medicine Revenue in Cell-free DNA Mutation Diagnostics Business (2019-2024)
11.7.5 Foundation Medicine Recent Development
11.8 Biocept
11.8.1 Biocept Company Details
11.8.2 Biocept Business Overview
11.8.3 Biocept Cell-free DNA Mutation Diagnostics Introduction
11.8.4 Biocept Revenue in Cell-free DNA Mutation Diagnostics Business (2019-2024)
11.8.5 Biocept Recent Development
11.9 Thermo Fisher Scientific
11.9.1 Thermo Fisher Scientific Company Details
11.9.2 Thermo Fisher Scientific Business Overview
11.9.3 Thermo Fisher Scientific Cell-free DNA Mutation Diagnostics Introduction
11.9.4 Thermo Fisher Scientific Revenue in Cell-free DNA Mutation Diagnostics Business (2019-2024)
11.9.5 Thermo Fisher Scientific Recent Development
11.10 Roche Diagnostics
11.10.1 Roche Diagnostics Company Details
11.10.2 Roche Diagnostics Business Overview
11.10.3 Roche Diagnostics Cell-free DNA Mutation Diagnostics Introduction
11.10.4 Roche Diagnostics Revenue in Cell-free DNA Mutation Diagnostics Business (2019-2024)
11.10.5 Roche Diagnostics Recent Development
11.11 Agilent Technologies
11.11.1 Agilent Technologies Company Details
11.11.2 Agilent Technologies Business Overview
11.11.3 Agilent Technologies Cell-free DNA Mutation Diagnostics Introduction
11.11.4 Agilent Technologies Revenue in Cell-free DNA Mutation Diagnostics Business (2019-2024)
11.11.5 Agilent Technologies Recent Development
11.12 Quest Diagnostics Incorporated
11.12.1 Quest Diagnostics Incorporated Company Details
11.12.2 Quest Diagnostics Incorporated Business Overview
11.12.3 Quest Diagnostics Incorporated Cell-free DNA Mutation Diagnostics Introduction
11.12.4 Quest Diagnostics Incorporated Revenue in Cell-free DNA Mutation Diagnostics Business (2019-2024)
11.12.5 Quest Diagnostics Incorporated Recent Development
11.13 Laboratory Corporation of America Holdings
11.13.1 Laboratory Corporation of America Holdings Company Details
11.13.2 Laboratory Corporation of America Holdings Business Overview
11.13.3 Laboratory Corporation of America Holdings Cell-free DNA Mutation Diagnostics Introduction
11.13.4 Laboratory Corporation of America Holdings Revenue in Cell-free DNA Mutation Diagnostics Business (2019-2024)
11.13.5 Laboratory Corporation of America Holdings Recent Development
11.14 Myriad Genetics
11.14.1 Myriad Genetics Company Details
11.14.2 Myriad Genetics Business Overview
11.14.3 Myriad Genetics Cell-free DNA Mutation Diagnostics Introduction
11.14.4 Myriad Genetics Revenue in Cell-free DNA Mutation Diagnostics Business (2019-2024)
11.14.5 Myriad Genetics Recent Development
11.15 BillionToOne
11.15.1 BillionToOne Company Details
11.15.2 BillionToOne Business Overview
11.15.3 BillionToOne Cell-free DNA Mutation Diagnostics Introduction
11.15.4 BillionToOne Revenue in Cell-free DNA Mutation Diagnostics Business (2019-2024)
11.15.5 BillionToOne Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Illumina Inc
Natera
Guardant
Freenome Holdings
GRAIL
Exact Sciences Corporation
Foundation Medicine
Biocept
Thermo Fisher Scientific
Roche Diagnostics
Agilent Technologies
Quest Diagnostics Incorporated
Laboratory Corporation of America Holdings
Myriad Genetics
BillionToOne Inc.
List of Tables
 Table 1. Global Cell-free DNA Mutation Diagnostics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of Kits
 Table 3. Key Players of Instruments
 Table 4. Key Players of Services
 Table 5. Global Cell-free DNA Mutation Diagnostics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 6. Global Cell-free DNA Mutation Diagnostics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 7. Global Cell-free DNA Mutation Diagnostics Market Size by Region (2019-2024) & (US$ Million)
 Table 8. Global Cell-free DNA Mutation Diagnostics Market Share by Region (2019-2024)
 Table 9. Global Cell-free DNA Mutation Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 10. Global Cell-free DNA Mutation Diagnostics Market Share by Region (2025-2030)
 Table 11. Cell-free DNA Mutation Diagnostics Market Trends
 Table 12. Cell-free DNA Mutation Diagnostics Market Drivers
 Table 13. Cell-free DNA Mutation Diagnostics Market Challenges
 Table 14. Cell-free DNA Mutation Diagnostics Market Restraints
 Table 15. Global Cell-free DNA Mutation Diagnostics Revenue by Players (2019-2024) & (US$ Million)
 Table 16. Global Cell-free DNA Mutation Diagnostics Market Share by Players (2019-2024)
 Table 17. Global Top Cell-free DNA Mutation Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell-free DNA Mutation Diagnostics as of 2023)
 Table 18. Ranking of Global Top Cell-free DNA Mutation Diagnostics Companies by Revenue (US$ Million) in 2023
 Table 19. Global 5 Largest Players Market Share by Cell-free DNA Mutation Diagnostics Revenue (CR5 and HHI) & (2019-2024)
 Table 20. Global Key Players of Cell-free DNA Mutation Diagnostics, Headquarters and Area Served
 Table 21. Global Key Players of Cell-free DNA Mutation Diagnostics, Product and Application
 Table 22. Global Key Players of Cell-free DNA Mutation Diagnostics, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Cell-free DNA Mutation Diagnostics Market Size by Type (2019-2024) & (US$ Million)
 Table 25. Global Cell-free DNA Mutation Diagnostics Revenue Market Share by Type (2019-2024)
 Table 26. Global Cell-free DNA Mutation Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 27. Global Cell-free DNA Mutation Diagnostics Revenue Market Share by Type (2025-2030)
 Table 28. Global Cell-free DNA Mutation Diagnostics Market Size by Application (2019-2024) & (US$ Million)
 Table 29. Global Cell-free DNA Mutation Diagnostics Revenue Market Share by Application (2019-2024)
 Table 30. Global Cell-free DNA Mutation Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 31. Global Cell-free DNA Mutation Diagnostics Revenue Market Share by Application (2025-2030)
 Table 32. North America Cell-free DNA Mutation Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 33. North America Cell-free DNA Mutation Diagnostics Market Size by Country (2019-2024) & (US$ Million)
 Table 34. North America Cell-free DNA Mutation Diagnostics Market Size by Country (2025-2030) & (US$ Million)
 Table 35. Europe Cell-free DNA Mutation Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 36. Europe Cell-free DNA Mutation Diagnostics Market Size by Country (2019-2024) & (US$ Million)
 Table 37. Europe Cell-free DNA Mutation Diagnostics Market Size by Country (2025-2030) & (US$ Million)
 Table 38. Asia-Pacific Cell-free DNA Mutation Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 39. Asia-Pacific Cell-free DNA Mutation Diagnostics Market Size by Region (2019-2024) & (US$ Million)
 Table 40. Asia-Pacific Cell-free DNA Mutation Diagnostics Market Size by Region (2025-2030) & (US$ Million)
 Table 41. Latin America Cell-free DNA Mutation Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 42. Latin America Cell-free DNA Mutation Diagnostics Market Size by Country (2019-2024) & (US$ Million)
 Table 43. Latin America Cell-free DNA Mutation Diagnostics Market Size by Country (2025-2030) & (US$ Million)
 Table 44. Middle East & Africa Cell-free DNA Mutation Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 45. Middle East & Africa Cell-free DNA Mutation Diagnostics Market Size by Country (2019-2024) & (US$ Million)
 Table 46. Middle East & Africa Cell-free DNA Mutation Diagnostics Market Size by Country (2025-2030) & (US$ Million)
 Table 47. Illumina Company Details
 Table 48. Illumina Business Overview
 Table 49. Illumina Cell-free DNA Mutation Diagnostics Product
 Table 50. Illumina Revenue in Cell-free DNA Mutation Diagnostics Business (2019-2024) & (US$ Million)
 Table 51. Illumina Recent Development
 Table 52. Natera Company Details
 Table 53. Natera Business Overview
 Table 54. Natera Cell-free DNA Mutation Diagnostics Product
 Table 55. Natera Revenue in Cell-free DNA Mutation Diagnostics Business (2019-2024) & (US$ Million)
 Table 56. Natera Recent Development
 Table 57. Guardant Company Details
 Table 58. Guardant Business Overview
 Table 59. Guardant Cell-free DNA Mutation Diagnostics Product
 Table 60. Guardant Revenue in Cell-free DNA Mutation Diagnostics Business (2019-2024) & (US$ Million)
 Table 61. Guardant Recent Development
 Table 62. Freenome Holdings Company Details
 Table 63. Freenome Holdings Business Overview
 Table 64. Freenome Holdings Cell-free DNA Mutation Diagnostics Product
 Table 65. Freenome Holdings Revenue in Cell-free DNA Mutation Diagnostics Business (2019-2024) & (US$ Million)
 Table 66. Freenome Holdings Recent Development
 Table 67. GRAIL Company Details
 Table 68. GRAIL Business Overview
 Table 69. GRAIL Cell-free DNA Mutation Diagnostics Product
 Table 70. GRAIL Revenue in Cell-free DNA Mutation Diagnostics Business (2019-2024) & (US$ Million)
 Table 71. GRAIL Recent Development
 Table 72. Exact Sciences Corporation Company Details
 Table 73. Exact Sciences Corporation Business Overview
 Table 74. Exact Sciences Corporation Cell-free DNA Mutation Diagnostics Product
 Table 75. Exact Sciences Corporation Revenue in Cell-free DNA Mutation Diagnostics Business (2019-2024) & (US$ Million)
 Table 76. Exact Sciences Corporation Recent Development
 Table 77. Foundation Medicine Company Details
 Table 78. Foundation Medicine Business Overview
 Table 79. Foundation Medicine Cell-free DNA Mutation Diagnostics Product
 Table 80. Foundation Medicine Revenue in Cell-free DNA Mutation Diagnostics Business (2019-2024) & (US$ Million)
 Table 81. Foundation Medicine Recent Development
 Table 82. Biocept Company Details
 Table 83. Biocept Business Overview
 Table 84. Biocept Cell-free DNA Mutation Diagnostics Product
 Table 85. Biocept Revenue in Cell-free DNA Mutation Diagnostics Business (2019-2024) & (US$ Million)
 Table 86. Biocept Recent Development
 Table 87. Thermo Fisher Scientific Company Details
 Table 88. Thermo Fisher Scientific Business Overview
 Table 89. Thermo Fisher Scientific Cell-free DNA Mutation Diagnostics Product
 Table 90. Thermo Fisher Scientific Revenue in Cell-free DNA Mutation Diagnostics Business (2019-2024) & (US$ Million)
 Table 91. Thermo Fisher Scientific Recent Development
 Table 92. Roche Diagnostics Company Details
 Table 93. Roche Diagnostics Business Overview
 Table 94. Roche Diagnostics Cell-free DNA Mutation Diagnostics Product
 Table 95. Roche Diagnostics Revenue in Cell-free DNA Mutation Diagnostics Business (2019-2024) & (US$ Million)
 Table 96. Roche Diagnostics Recent Development
 Table 97. Agilent Technologies Company Details
 Table 98. Agilent Technologies Business Overview
 Table 99. Agilent Technologies Cell-free DNA Mutation Diagnostics Product
 Table 100. Agilent Technologies Revenue in Cell-free DNA Mutation Diagnostics Business (2019-2024) & (US$ Million)
 Table 101. Agilent Technologies Recent Development
 Table 102. Quest Diagnostics Incorporated Company Details
 Table 103. Quest Diagnostics Incorporated Business Overview
 Table 104. Quest Diagnostics Incorporated Cell-free DNA Mutation Diagnostics Product
 Table 105. Quest Diagnostics Incorporated Revenue in Cell-free DNA Mutation Diagnostics Business (2019-2024) & (US$ Million)
 Table 106. Quest Diagnostics Incorporated Recent Development
 Table 107. Laboratory Corporation of America Holdings Company Details
 Table 108. Laboratory Corporation of America Holdings Business Overview
 Table 109. Laboratory Corporation of America Holdings Cell-free DNA Mutation Diagnostics Product
 Table 110. Laboratory Corporation of America Holdings Revenue in Cell-free DNA Mutation Diagnostics Business (2019-2024) & (US$ Million)
 Table 111. Laboratory Corporation of America Holdings Recent Development
 Table 112. Myriad Genetics Company Details
 Table 113. Myriad Genetics Business Overview
 Table 114. Myriad Genetics Cell-free DNA Mutation Diagnostics Product
 Table 115. Myriad Genetics Revenue in Cell-free DNA Mutation Diagnostics Business (2019-2024) & (US$ Million)
 Table 116. Myriad Genetics Recent Development
 Table 117. BillionToOne Company Details
 Table 118. BillionToOne Business Overview
 Table 119. BillionToOne Cell-free DNA Mutation Diagnostics Product
 Table 120. BillionToOne Revenue in Cell-free DNA Mutation Diagnostics Business (2019-2024) & (US$ Million)
 Table 121. BillionToOne Recent Development
 Table 122. Research Programs/Design for This Report
 Table 123. Key Data Information from Secondary Sources
 Table 124. Key Data Information from Primary Sources
 Table 125. Authors List of This Report


List of Figures
 Figure 1. Cell-free DNA Mutation Diagnostics Picture
 Figure 2. Global Cell-free DNA Mutation Diagnostics Market Size Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Cell-free DNA Mutation Diagnostics Market Share by Type: 2023 VS 2030
 Figure 4. Kits Features
 Figure 5. Instruments Features
 Figure 6. Services Features
 Figure 7. Global Cell-free DNA Mutation Diagnostics Market Size by Application (2024-2030) & (US$ Million)
 Figure 8. Global Cell-free DNA Mutation Diagnostics Market Share by Application: 2023 VS 2030
 Figure 9. Hoispital Case Studies
 Figure 10. Clinic Case Studies
 Figure 11. Laboratories Case Studies
 Figure 12. Others Case Studies
 Figure 13. Cell-free DNA Mutation Diagnostics Report Years Considered
 Figure 14. Global Cell-free DNA Mutation Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 15. Global Cell-free DNA Mutation Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 16. Global Cell-free DNA Mutation Diagnostics Market Share by Region: 2023 VS 2030
 Figure 17. Global Cell-free DNA Mutation Diagnostics Market Share by Players in 2023
 Figure 18. Global Top Cell-free DNA Mutation Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell-free DNA Mutation Diagnostics as of 2023)
 Figure 19. The Top 10 and 5 Players Market Share by Cell-free DNA Mutation Diagnostics Revenue in 2023
 Figure 20. North America Cell-free DNA Mutation Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 21. North America Cell-free DNA Mutation Diagnostics Market Share by Country (2019-2030)
 Figure 22. United States Cell-free DNA Mutation Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 23. Canada Cell-free DNA Mutation Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 24. Europe Cell-free DNA Mutation Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 25. Europe Cell-free DNA Mutation Diagnostics Market Share by Country (2019-2030)
 Figure 26. Germany Cell-free DNA Mutation Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 27. France Cell-free DNA Mutation Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 28. U.K. Cell-free DNA Mutation Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 29. Italy Cell-free DNA Mutation Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. Russia Cell-free DNA Mutation Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 31. Nordic Countries Cell-free DNA Mutation Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 32. Asia-Pacific Cell-free DNA Mutation Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 33. Asia-Pacific Cell-free DNA Mutation Diagnostics Market Share by Region (2019-2030)
 Figure 34. China Cell-free DNA Mutation Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 35. Japan Cell-free DNA Mutation Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 36. South Korea Cell-free DNA Mutation Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 37. Southeast Asia Cell-free DNA Mutation Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 38. India Cell-free DNA Mutation Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 39. Australia Cell-free DNA Mutation Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 40. Latin America Cell-free DNA Mutation Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 41. Latin America Cell-free DNA Mutation Diagnostics Market Share by Country (2019-2030)
 Figure 42. Mexico Cell-free DNA Mutation Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 43. Brazil Cell-free DNA Mutation Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 44. Middle East & Africa Cell-free DNA Mutation Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 45. Middle East & Africa Cell-free DNA Mutation Diagnostics Market Share by Country (2019-2030)
 Figure 46. Turkey Cell-free DNA Mutation Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 47. Saudi Arabia Cell-free DNA Mutation Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 48. UAE Cell-free DNA Mutation Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 49. Illumina Revenue Growth Rate in Cell-free DNA Mutation Diagnostics Business (2019-2024)
 Figure 50. Natera Revenue Growth Rate in Cell-free DNA Mutation Diagnostics Business (2019-2024)
 Figure 51. Guardant Revenue Growth Rate in Cell-free DNA Mutation Diagnostics Business (2019-2024)
 Figure 52. Freenome Holdings Revenue Growth Rate in Cell-free DNA Mutation Diagnostics Business (2019-2024)
 Figure 53. GRAIL Revenue Growth Rate in Cell-free DNA Mutation Diagnostics Business (2019-2024)
 Figure 54. Exact Sciences Corporation Revenue Growth Rate in Cell-free DNA Mutation Diagnostics Business (2019-2024)
 Figure 55. Foundation Medicine Revenue Growth Rate in Cell-free DNA Mutation Diagnostics Business (2019-2024)
 Figure 56. Biocept Revenue Growth Rate in Cell-free DNA Mutation Diagnostics Business (2019-2024)
 Figure 57. Thermo Fisher Scientific Revenue Growth Rate in Cell-free DNA Mutation Diagnostics Business (2019-2024)
 Figure 58. Roche Diagnostics Revenue Growth Rate in Cell-free DNA Mutation Diagnostics Business (2019-2024)
 Figure 59. Agilent Technologies Revenue Growth Rate in Cell-free DNA Mutation Diagnostics Business (2019-2024)
 Figure 60. Quest Diagnostics Incorporated Revenue Growth Rate in Cell-free DNA Mutation Diagnostics Business (2019-2024)
 Figure 61. Laboratory Corporation of America Holdings Revenue Growth Rate in Cell-free DNA Mutation Diagnostics Business (2019-2024)
 Figure 62. Myriad Genetics Revenue Growth Rate in Cell-free DNA Mutation Diagnostics Business (2019-2024)
 Figure 63. BillionToOne Revenue Growth Rate in Cell-free DNA Mutation Diagnostics Business (2019-2024)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global Cell Free DNA cfDNA Testing Market Research Report 2024
Global Cell Free DNA cfDNA Kits Market Research Report 2024
Global Cell free Tumor DNA Detection Market Research Report 2025
Global Free DNA Extraction Kit Market Research Report 2024
Global Circulating Tumor DNA Diagnostics Market Research Report 2025
Global Cell Free DNA cfDNA Blood Collection Tube Market Research Report 2024
Global Liquid Biopsy For Cancer Diagnostics Market Research Report 2024
Global ctDNA Detection Market Research Report 2025
Global Cell Free Circulating Tumor DNA ctDNA Market Research Report 2024
Global Human Gene Mutation Detection Kit Market Research Report 2024
Global Molecular Diagnostics Cancer Market Insights Forecast to 2030
Global ctDNA Detection Kit Market Research Report 2024
Global Point of care Molecular Diagnostic Solution Market Research Report 2025
Molecular Diagnostics Infectious Disease Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Microbial Cell free DNA mcfDNA Detection Market Research Report 2024
Global Free DNA Room Temperature Storage Tube Market Research Report 2025
Global Liquid Biopsy Diagnostic Tool Market Research Report 2025
Global Non Invasive Cancer Detection Market Research Report 2024
Global Molecular Diagnostics in Infectious Disease Testing Market Research Report 2024
Global Non Invasive Prenatal DNA Testing Service Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions